Sorry Krugerrand I did the maths nearly 2 years ago. I just remember 529 and have mentioned a few times.
Regards Fornieri coming to my mind . Well he just
happens to be the ex CEO , Chairman and Managing
Director of Mithra. The same man Scott Richards our
CEO did both Nuvaring gx and Nextellis contracts
with . Dance with the Devil and there may well be
consequences not to our benefit.
That is exactly my point in relation to Myring if there
is no profit, why bother. ?? I think Mayne may now
be coming to the same conclusion. No mention lately.
Regards Austria I just randomly selected a European
country as an example. My point is
we paid $529m for
360 million population. Europe 730 million or so paid
peanuts in comparison. I think Richards has been
conned into believing because Americans spend more
on pharmaceuticals Mayne should pay more for Nextellis. Sorry Krugerrand but Scott already proved
his poor judgment with $900m loss on Teva 5+ years
ago which we are still paying for. He is not up to it and
He along with Corbett and BM have skills or experience
min international negotiations. They have proven it
before.
General Discussion Topics, page-28
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.26 |
Change
-0.020(0.47%) |
Mkt cap ! $362.4M | |||
| Open | High | Low | Value | Volume |
| $4.28 | $4.37 | $4.20 | $1.216M | 284.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12486 | $4.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.27 | 1060 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |